Detection of a non-Hodgkin's lymphoma by capromab pendetide scintigraphy (ProstaScint) in a patient with prostate carcinoma

Urology

Volumn 60, Issue 3, 2002, Pages 514-

  Zanzi, Italo ^a   Stark, Richard ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPROMAB PENDETIDE IN 111; CYCLOPHOSPHAMIDE; PREDNISONE; PROSTATE SPECIFIC ANTIGEN; TRACER; VINCRISTINE;

ABDOMINAL MASS; AGED; ANTIGEN DETECTION; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER SCINTISCANNING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; HUMAN; LYMPHADENOPATHY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; SCORING SYSTEM; TREATMENT OUTCOME; TUMOR BIOPSY;

EID: 0036754572     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0090-4295(02)01835-6     Document Type: Article

References (12)

1. Haseman M.K., Rosenthal S.A., Polascik T.J. Capromab pendetide imaging of prostate cancer. Cancer Biotherapy Radiopharm. 15:2000;131-140.
2. Elgamal A.-A.A., Troychak M.J., Murphy G.P. ProstaScint scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy analysis of 136 scans of 100 patients . Prostate. 37:1998;261-269.
3. Michaels E.K., Blend M., Quintana J.C. Indium-111 capromab pendetide unexpectedly localizes to renal cell carcinoma. J Urol. 161:1999;597-598.
4. Zucker R.J., Bradley Y.C. Indium-111 capromab pendetide (ProstaScint) uptake in a meningioma. Clin Nucl Med. 26:2001;568-569.
5. Scott D.L., Halkar R.K., Fischer A., et al. False-positive indium-111 capromab pendetide scan due to benign myelolipoma. J Urol. 165:2001;910-911.
6. Kahn A., Caride U.J. Indium-111 capromab pendetide (ProstaScint) uptake in neurofibromatosis. Urology. 56:2000;154.
7. Gros R., Richter S., Bechar L. Prostatic carcinoma with concomitant non-Hodgkin lymphoma report of two cases . Urol Int. 39:1984;121-122.
8. Bostwick D.G., Iczkowski K.A., Amin M.B., et al. Malignant lymphoma involving the prostate report of 62 cases . Cancer. 83:1998;732-738.
9. Eisenberger C.F., Walsh P.C., Eisenberger M.A., et al. Incidental non-Hodgkin's lymphoma in patients with localized prostate cancer. Urology. 53:1999;175-179.
10. Johnstone P.A.S., Powell C.R., Riffenburgh R., et al. Second primary malignancies in T1-3N0 prostate cancer patients treated with radiation therapy with 10-year follow-up. J Urol. 159:1998;946-949.
11. Stamey T.A., Warrington J.A., Caldwell M.C., et al. Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. J Urol. 166:2001;2171-2177.
12. Chang S.S., O'Keefe D.S., Bacich D.J., et al. Prostate-specific membrane antigen is produced in tumor-associated neurovasculature. Clin Cancer Res. 5:1999;2674-2681.